Showing results (161-170 of 176) with videos related to
Sort By:
Pageof 18
Chemical Biology & Drug Design|July 22, 2020
Antihypertensive activity and molecular interactions of irbesartan in complex with 2-hydroxypropyl-β-cyclodextrinGeorgios Leonis, Eirini Christodoulou, Dimitrios Ntountaniotis, et al.Molecules (Basel, Switzerland)|September 5, 2020
Synthetic Analogues of Aminoadamantane as Influenza Viral Inhibitors-In Vitro, In Silico and QSAR StudiesRadoslav Chayrov, Nikolaos A Parisis, Maria V Chatziathanasiadou, et al.Current Medicinal Chemistry|November 18, 2015
Leveraging NMR and X-ray Data of the Free Ligands to Build Better Drugs Targeting Angiotensin II Type 1 G-Protein Coupled ReceptorTahsin F Kellici, Dimitrios Ntountaniotis, Eftichia Kritsi, et al.Computational and Structural Biotechnology Journal|April 18, 2022
Discovery of a new generation of angiotensin receptor blocking drugs: Receptor mechanisms and in silico binding to enzymes relevant to SARS-CoV-2Harry Ridgway, Graham J Moore, Thomas Mavromoustakos, et al.Biochimica Et Biophysica Acta. General Subjects|June 11, 2018
Exploring the oxidation and iron binding profile of a cyclodextrin encapsulated quercetin complex unveiled a controlled complex dissociation through a chemical stimulusDimitrios A Diamantis, Sarka Ramesova, Christos M Chatzigiannis, et al.Journal of Biomolecular Structure & Dynamics|September 9, 2021
Molecular investigation of artificial and natural sweeteners as potential anti-inflammatory agentsEleni Chontzopoulou, Christina D Papaemmanouil, Maria V Chatziathanasiadou, et al.Molecular Pharmaceutics|February 10, 2015
Investigation of the interactions of silibinin with 2-hydroxypropyl-β-cyclodextrin through biophysical techniques and computational methodsTahsin F Kellici, Dimitrios Ntountaniotis, Georgios Leonis, et al.Free Radical Biology & Medicine|August 22, 2020
Enhancement of glioblastoma multiforme therapy through a novel Quercetin-Losartan hybridAntonis D Tsiailanis, Alexander Renziehausen, Sofia Kiriakidi, et al.Biochimica Et Biophysica Acta|August 22, 2012
Comparative study of the AT₁ receptor prodrug antagonist candesartan cilexetil with other sartans on the interactions with membrane bilayersCharalambos Fotakis, Grigorios Megariotis, Dionysios Christodouleas, et al.European Journal of Medicinal Chemistry|February 5, 2013
Rational design, efficient syntheses and biological evaluation of N,N'-symmetrically bis-substituted butylimidazole analogs as a new class of potent Angiotensin II receptor blockersGeorge Agelis, Amalia Resvani, Catherine Koukoulitsa, et al.Pageof 18